SINGLE-AGENT LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE LYMPHOMA PATIENTS

被引：0
|
作者：
Puccini, B. [1 ]
Chitarrelli, I. [1 ]
Antognoli, G. [1 ]
Fabbri, A. [1 ]
Rigacci, L. [1 ]
Lenoci, M. P. [1 ]
Lauria, F. [1 ]
Bosi, A. [1 ]
机构：
[1] Dept Hematol, Florence, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0687
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [31] Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
    Marie Maerevoet
    Josee M. Zijlstra
    George Follows
    Rene-Olivier Casasnovas
    J. S. P. Vermaat
    Nagesh Kalakonda
    Andre Goy
    Sylvain Choquet
    Eric Van Den Neste
    Brian Hill
    Catherine Thieblemont
    Federica Cavallo
    Fatima De la Cruz
    John Kuruvilla
    Nada Hamad
    Ulrich Jaeger
    Paolo Caimi
    Ronit Gurion
    Krzysztof Warzocha
    Sameer Bakhshi
    Juan-Manuel Sancho
    Michael Schuster
    Miklos Egyed
    Fritz Offner
    Theodoros P. Vassilakopoulos
    Priyanka Samal
    Matthew Ku
    Xiwen Ma
    Kelly Corona
    Kamal Chamoun
    Jatin Shah
    Sharon Shacham
    Michael G. Kauffman
    Miguel Canales
    Journal of Hematology & Oncology, 14
  • [32] Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
    Maerevoet, Marie
    Zijlstra, Josee M.
    Follows, George
    Casasnovas, Rene-Olivier
    Vermaat, J. S. P.
    Kalakonda, Nagesh
    Goy, Andre
    Choquet, Sylvain
    Van den Neste, Eric
    Hill, Brian
    Thieblemont, Catherine
    Cavallo, Federica
    De la Cruz, Fatima
    Kuruvilla, John
    Hamad, Nada
    Jaeger, Ulrich
    Caimi, Paolo
    Gurion, Ronit
    Warzocha, Krzysztof
    Bakhshi, Sameer
    Sancho, Juan-Manuel
    Schuster, Michael
    Egyed, Miklos
    Offner, Fritz
    Vassilakopoulos, Theodoros P.
    Samal, Priyanka
    Ku, Matthew
    Ma, Xiwen
    Corona, Kelly
    Chamoun, Kamal
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Canales, Miguel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [33] Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
    Lenz, Georg
    Hawkes, Eliza
    Verhoef, Gregor
    Haioun, Corinne
    Thye, Lim Soon
    Heo, Dae Seog
    Ardeshna, Kirit
    Chong, Geoffrey
    Christensen, Jacob Haaber
    Shi, Vivian
    Lippert, Susanne
    Niemeyer, Florian
    Piraino, Paolo
    Pena, Carol Elaine
    Buvaylo, Viktoriya
    Childs, Barrett H.
    Gorbatchevsky, Igor
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma
    Venkatesh, H
    Di Bella, N
    Flynn, TP
    Vellek, MJ
    Boehm, KA
    Asmar, L
    CLINICAL LYMPHOMA, 2004, 5 (02): : 110 - 115
  • [35] Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
    Khan, Niloufer
    Hantel, Andrew
    Knoebel, Randall W.
    Artz, Andrew
    Larson, Richard A.
    Godley, Lucy A.
    Thirman, Michael J.
    Liu, Hongtao
    Churpek, Jane E.
    King, Darren
    Odenike, Olatoyosi
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2127 - 2133
  • [36] SINGLE-AGENT LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA FOLLOWING BORTEZOMIB: EFFICACY, SAFETY AND PHARMACOKINETICS FROM THE MULTICENTER PHASE II MCL-001 "EMERGE" TRIAL
    Goy, A.
    Sinha, R.
    Vose, J.
    Adler, H.
    Bernstein, S.
    Robertson, M.
    Chen, N.
    Zhang, L.
    Cicero, S.
    Fu, T.
    Witzig, T.
    HAEMATOLOGICA, 2013, 98 : 478 - 478
  • [37] Schedule of bortezomib administration may be an important determinant of single-agent activity in patients with relapsed or refractory follicular (FL) lymphoma and mantle cell lymphoma (MCL)
    O'Connor, O.
    Hamlin, P.
    Moskowitz, C.
    Straus, D.
    Noy, A.
    Wright, J.
    Neylon, E.
    MacGregor-Cortelli, B.
    Portlock, C.
    Zelenetz, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients
    Zinzani, Pier Luigi
    Vitolo, Umberto
    Viviani, Simonetta
    Corradini, Paolo
    Motta, Giovanna
    Tani, Monica
    Cascavilla, Nicola
    Hohaus, Stefan
    Merli, Francesco
    Argnani, Lisa
    Broccoli, Alessandro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07): : 404 - 408
  • [39] LENALIDOMIDE PLUS RITUXIMAB IN ELDERLY PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA
    Della Cioppa, P.
    Lucania, A.
    Esposito, M.
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2015, 100 : 151 - 151
  • [40] Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma
    Kuruvilla, John
    Taylor, Diane
    Wang, Lisa
    Blattler, Chantale
    Keating, Armand
    Crump, Michael
    BLOOD, 2008, 112 (11) : 1049 - 1049
12345